Startups
SK pharmteco is the single market-facing team comprised of SK biotek and AMPAC Fine Chemicals. Crea
Overview
Location
United States, California, Rancho Cordova
Employees
1001-5000
Total raised
$260M
Founded date
2019
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 23, 2025 | SK pharmteco Investing $6.1 Million To Expand Peptide Manufacturing Capabilities In California | SK pharmteco, a global contract development and manufacturing organization (CDMO), announced a $6.1 million investment to expand its Rancho Cordova, California facility. The funding will establish a new laboratory and CGMP kilo-scale facili... |
| Sep 30, 2024 | SK pharmteco: Global Contract Development Company Raises $260 Million | SK pharmteco, a global contract development and manufacturing organization (CDMO), announced a major expansion of its small molecule and peptide production capabilities with $260 million in funding to construct a new state-of-the-art facili... |
| Oct 18, 2023 | SK pharmteco to showcase its extensive APIs and CGT capabilities in CPHI 2023 | With a dedicated booth in the main exhibition hall, SK pharmteco solidifies its global position as the most trusted CDMO partner in the pharmaceutical industry Appoints Chief Commercial Officer Andrew Fenny to strengthen its global marketin... |
| Jun 23, 2023 | SK pharmteco doubles viral vector production capacity in Europe | Yposkesi, SK pharmteco's clinical and commercial viral vector manufacturing subsidiary for Cell and Gene Therapy (C>), completes its second bioproduction facility and doubles its manufacturing footprint to 10,000m2, one of the largest... |
| Nov 2, 2022 | SK pharmteco appoints Joerg Ahlgrimm as CEO to spearhead the next phase of company growth and innovation | - Joerg Ahlgrimm brings 25 years of expertise in pharmaceuticals and innovative cell and gene therapies - SK pharmteco expands pharmaceutical drug production and advances cell and gene therapy production - Annual sales expected to exceed KR... |
Reviews 0
FAQ about SK pharmteco
When was SK pharmteco founded?
SK pharmteco was founded in 2019.
How much funding has SK pharmteco raised?
SK pharmteco has raised $260M in total across 1 funding round.
What has the press written about SK pharmteco?
Parsers VC has collected 6 articles mentioning SK pharmteco, among them “SK pharmteco Investing $6.1 Million To Expand Peptide Manufacturing Capabilities In California” (Oct 23, 2025) and “SK pharmteco: Global Contract Development Company Raises $260 Million” (Sep 30, 2024).
Is SK pharmteco still active?
Yes, SK pharmteco is active; its latest activity on Parsers VC dates from Oct 30, 2025.